Singapore, March 10 -- CSL, an Australia-based global biopharma leader, broke ground for the expansion of its state-of-the-art manufacturing facility in Kankakee, Illinois in the US. The expansion, a cornerstone of the company's global manufacturing growth strategy and effort to expand its US production presence, was officially announced with state and local officials, including Illinois Governor JB Pritzker, Illinois State Senator Patrick Joyce, and other key dignitaries.

The newly expanded facility will substantially increase the company's ability to produce life-sustaining, plasma-derived therapies for people living with rare and serious diseases and other acute medical issues while bringing hundreds of new, highly skilled positions t...